Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
Unordered list
Bold text
Emphasis
Superscript
Subscript
GLP-1 medications offer a promising path to weight loss, but understanding their impact on body composition, particularly muscle mass, is crucial for long-term health. Research has revealed specific mechanisms by which these medications affect muscle tissue, with quantitative evidence showing that lean mass loss accounts for approximately 40% of total weight loss with semaglutide and up to 60% with liraglutide (Neeland et al., 2024). This post explores this relationship and provides evidence-based strategies to maintain a healthy muscle-to-fat ratio during your weight loss journey.
GLP-1 (glucagon-like peptide-1) medications are a class of drugs originally developed to treat type 2 diabetes. They've become increasingly popular for their effectiveness in weight management, helping people achieve significant weight loss. These medications work by mimicking the natural hormones in your body that regulate appetite and blood sugar. While incredibly helpful, it's important to understand how these medications work and their potential effects to use them safely and effectively.
GLP-1 drugs work by mimicking the effects of incretin hormones, which your body naturally produces after you eat. These hormones play a crucial role in regulating blood sugar and appetite. GLP-1 medications enhance insulin secretion, which helps your body use sugar more efficiently. They also suppress the release of glucagon, a hormone that raises blood sugar.
Additionally, these medications slow gastric emptying, meaning food stays in your stomach longer, increasing feelings of fullness and reducing appetite. This combination contributes to weight loss by controlling hunger and improving metabolic function. Research shows that GLP-1 medications primarily induce weight loss through appetite inhibition and reduced energy intake, which leads to caloric restriction (Blundell et al., 2017).
Several GLP-1 receptor agonists are currently available, each with slightly different properties and administration methods. Some common GLP-1 medications include:
These medications are typically administered through injection, either daily or weekly, depending on the specific drug. Clinical trials have shown that GLP-1 medications can lead to substantial weight loss, with different potencies: "liraglutide showed a placebo-corrected weight loss of around 5%, semaglutide 12%, and tirzepatide 18%" (Wilding et al., 2021; O'Neil et al., 2018; Jastreboff et al., 2022). However, it's important to remember that these medications are most effective when combined with a healthy diet and regular exercise.
For helpful guidance on food choices while using GLP-1 medications, check out this article. Adding regular 3D body scans can provide detailed insights into your body composition changes throughout your weight loss journey.
GLP-1 receptor agonists, like semaglutide, are quite effective for weight loss. They work by interacting with GLP-1 receptors in your brain, which helps regulate your appetite and reduce cravings. This can lead to significant weight loss for many individuals.
It's a common concern: if I lose weight quickly, will I lose muscle too? Research indicates that rapid weight loss can lead to a greater loss of lean mass compared to a more gradual approach. During caloric restriction and weight loss, the balance between protein synthesis and degradation shifts toward greater protein degradation relative to synthesis, resulting in net muscle loss (Breen et al., 2013).
Studies have identified that two major protein degradation pathways are involved in this process: the ubiquitin-proteasome system and the autophagy-lysosome system (Lecker et al., 2006; Grumati & Bonaldo, 2012). Multiple signaling pathways regulate this balance, including mTOR (mechanistic target of rapamycin), which is a key regulator of protein synthesis.
Maintaining healthy muscle mass is important for a strong immune system, efficient wound healing, and overall well-being. To learn more about the relationship between rapid weight loss and muscle loss, take a look at this article.
While some muscle loss might occur with GLP-1 treatment, it's generally proportional to the overall weight loss. Systematic reviews and meta-analyses indicate that lean mass loss accounts for approximately 40% of total weight loss with semaglutide and up to 60% with liraglutide (Neeland et al., 2024).
However, the relationship between GLP-1 agonists and muscle is complex. Some research suggests that liraglutide and semaglutide may protect skeletal muscle against obesity-induced muscle atrophy via the SIRT1 pathway. Furthermore, GLP-1 agonists appear to improve muscle quality by reducing muscle fat infiltration, even as muscle quantity decreases (Drucker, 2018).
Lean mass loss accounts for ~40% of weight loss with semaglutide and up to 60% with liraglutide
Neeland et al., 2024
Some experts argue that skeletal muscle changes appear to be "adaptive" rather than pathological - changes in muscle volume are commensurate with what would be expected given aging, disease status, and weight loss achieved. The improvement in insulin sensitivity and muscle fat infiltration likely contributes to an adaptive process with improved muscle quality, potentially lowering the probability for loss in strength and function (Neeland et al., 2024).
You can absolutely take steps to preserve and even build muscle while using these medications. Focusing on maintaining muscle mass can also help prevent weight regain. This article offers valuable insights into preserving muscle during weight loss.
The key takeaway? You can achieve significant weight loss and maintain healthy muscle with the right strategies. Learn more about how ShapeScale can help you accurately track your body composition with our 3D body scanning technology.
While GLP-1 medications can be effective for weight loss, prioritizing muscle preservation during your journey is important. A combined approach of exercise and nutrition will help you achieve optimal results. ShapeScale's 3D body scanning technology can be a valuable tool for accurately tracking changes in your body composition, including muscle mass, throughout your weight loss journey. Learn more about how ShapeScale can support your wellness business.
Strength training is key to counteracting potential muscle loss while taking GLP-1 medications. The strongest evidence supports a combination of resistance training and adequate protein intake for preserving muscle mass during weight loss, including with GLP-1 agonists. Neither intervention alone appears to be as effective as the combination, suggesting a synergistic effect that should be leveraged in clinical practice (Cermak et al., 2012; Morton et al., 2018).
Resistance exercises stimulate muscle growth and help preserve lean mass as you lose weight. This not only helps you maintain a healthy metabolism but also improves your overall physical function and strength.
A balanced resistance training program should target all major muscle groups. Incorporate exercises like:
You can use free weights, resistance bands, or weight machines. Even bodyweight exercises can be effective. For resistance training, the evidence supports moderate to high intensity resistance training performed 2-3 times per week for 30-60 minutes per session. Programs should focus on major muscle groups with progressive overload (gradually increasing resistance) (Stastny et al., 2016).
Research shows that even short sessions of resistance training can make a difference.
Start with a weight or resistance level that feels challenging but allows you to maintain good form. Aim for two to three resistance training sessions per week, allowing rest days between workouts for muscle recovery. As you get stronger, gradually increase the weight, resistance, or number of repetitions.
For those unable to tolerate high-load resistance training, particularly elderly individuals, blood-flow-restricted low-load resistance training (20-30% of one repetition maximum) has been reported as an effective sarcopenia countermeasure.
Regular exercise is crucial for overall health and muscle maintenance while using GLP-1 medications. For businesses in the wellness industry, ShapeScale offers accurate body composition analysis to help clients track their progress and stay motivated. Book a demo today to see how ShapeScale can benefit your clients.
In addition to strength training, include regular cardiovascular exercise. Activities like brisk walking, jogging, cycling, or swimming support overall health and can contribute to muscle maintenance. Low-impact, weight-bearing exercises like walking are particularly beneficial for preserving bone density, which is important for long-term health.
Staying active is key for overall well-being while using GLP-1 medications. Remember to listen to your body and adjust the intensity and duration of your workouts as needed. If you're a personal trainer or operate a health club, consider incorporating ShapeScale's technology to provide your clients with precise body composition data and personalized fitness plans. Explore ShapeScale's pricing plans to find the perfect fit for your business.
Maintaining muscle mass while using GLP-1 medications for weight loss requires a strategic approach to nutrition. It's not just about what you eat, but also how much. By understanding how these medications affect your body and following some key guidelines, you can support your fitness goals while maximizing your weight loss journey.
A good first step is to find a healthcare provider who can help you develop a personalized plan.
GLP-1 medications can decrease appetite, so it's crucial to prioritize protein. As one dietitian notes, getting enough protein and staying physically active are even more critical with GLP-1s to maximize fat loss and maintain muscle.
Regarding protein intake, higher than RDA (0.8g/kg/day) protein intake is recommended. Specific recommendations range from 1.0-1.6 g/kg/day, with those at higher sarcopenia risk potentially needing the higher end of this range (Deutz et al., 2014). Distribution of protein intake across meals is important, with a target of 25-30g of high-quality protein per meal to maximally stimulate muscle protein synthesis (Paddon-Jones & Rasmussen, 2009).
Protein provides the building blocks your muscles need for repair and growth, especially important when you're strength training. Work with a registered dietitian or your healthcare provider to determine the ideal protein intake for you.
While protein is essential, finding the right balance of macronutrients—protein, carbohydrates, and fats—is key for overall health and muscle maintenance. A recommended approach emphasizes vegetables, fruits, whole grains, lean protein sources, low-fat dairy or dairy alternatives, and healthy fats. This balanced approach ensures you're getting the nutrients you need to support your body's functions while effectively managing weight loss.
Planning your meals can make a big difference in staying on track with your nutrition goals while using GLP-1 medications. Some helpful tips include prioritizing protein and fiber in each meal and eating consistently throughout the day to manage blood sugar and minimize side effects.
Leucine-enriched protein sources appear particularly beneficial, especially for elderly individuals who show anabolic resistance. Studies found that "ingestion of leucine-enriched essential amino acids stimulates muscle protein synthesis to a similar extent in young and elderly (although the response was delayed in the elderly)" (Churchward-Venne et al., 2013).
Staying hydrated is also essential. Consider limiting or avoiding alcohol and nutrient-poor foods, which can hinder your progress.
Don't underestimate the importance of hydration for overall health, including muscle function and recovery. Adequate hydration supports your workouts and helps your body perform at its best. Carry a water bottle with you and make a conscious effort to drink regularly, especially before, during, and after exercise.
Successfully integrating GLP-1 medications into a healthy lifestyle requires a multifaceted approach. It's not just about the medication itself; it's about building sustainable habits that support long-term well-being. Here's how to approach weight loss and muscle maintenance strategically:
Weight loss journeys are unique to each individual. While GLP-1 medications can be effective, it's important to have realistic expectations about the process. Remember that all weight loss, regardless of the method, can lead to some muscle loss. This is a natural physiological response and not necessarily a cause for concern.
During caloric restriction and weight loss, the balance between protein synthesis and degradation shifts toward greater protein degradation relative to synthesis, resulting in net muscle loss (Breen et al., 2013). Two major protein degradation pathways are involved: the ubiquitin-proteasome system and the autophagy-lysosome system (Lecker et al., 2006; Grumati & Bonaldo, 2012).
The key is to mitigate this loss through a dedicated exercise program. Focusing on strength training can help preserve your existing muscle mass as you lose weight.
GLP-1 medications affect people differently. What works for one person might not work for another. A personalized approach is crucial, especially when it comes to preserving muscle mass.
Consider factors like your starting body composition, activity level, and dietary habits. If you have a higher percentage of lean body mass, you may need to pay extra attention to strength training to maintain it. Working with a healthcare professional can help you tailor a plan specific to your needs and goals.
The most effective approach to maintaining muscle while using GLP-1 medications combines regular exercise with a balanced diet. Prioritize strength training to preserve and build lean muscle. Combine this with a diet rich in protein and fiber to support muscle growth and overall health.
Don't underestimate the importance of consistent meals and proper hydration. These factors play a significant role in how your body responds to both the medication and your fitness efforts. Remember that nutrition and exercise work synergistically; one complements the other.
Regularly monitoring your progress is essential for long-term success. Track your weight, body composition, and how you feel. Consider using tools like 3D body scans to accurately measure your body composition changes. This data will help you and your healthcare provider make informed decisions about your treatment plan.
Don't be afraid to adjust your strategies based on your progress. What works in the beginning might need tweaking down the line. Consistency and adaptation are key to achieving your goals. Regular check-ins with a healthcare provider or registered dietitian can provide valuable support and guidance throughout your journey.
Successfully using GLP-1 medication for weight loss while preserving muscle involves a multi-faceted approach. A critical component is professional guidance and regular monitoring. This section explores the importance of working with healthcare providers and dietitians, conducting regular body composition assessments, and adjusting treatment plans based on your progress.
Healthcare providers, including registered dietitians, are vital to your GLP-1 journey. They offer personalized guidance tailored to your needs and health status. Pairing GLP-1s with a dietitian ensures your nutrition plan optimizes your medication's effectiveness.
Dietitians can create meal plans that support muscle maintenance while managing potential side effects, a crucial aspect discussed in resources like this article on dietitians' roles in GLP-1 therapy. They can also help you make informed food choices that align with your weight loss goals and overall health.
Research involving interviews with dietitians has identified key elements to improve both the efficacy of GLP-1 treatments and patient outcomes. These elements include personalized dietary plans, strategies for managing side effects, and ongoing support to help patients maintain long-term lifestyle changes (Kahan et al., 2023).
Collaborating with a healthcare provider ensures you receive the support and expertise necessary for a safe and effective experience. For businesses in the wellness industry, this integrated approach can be a valuable selling point, demonstrating a commitment to client well-being. Learn more about how ShapeScale can support your business by booking a demo.
Regular body composition assessments are essential for tracking progress and ensuring you're losing fat, not muscle. Regular assessments of lean body mass are crucial because weight lost during GLP-1 treatment can sometimes come from lean body mass.
Initial body composition assessment is important before starting GLP-1 agonists, ideally using DEXA or bioelectrical impedance analysis (Lee & Gallagher, 2008). Regular monitoring of body composition during treatment helps track changes in muscle mass. Functional assessments (strength testing, physical performance measures) provide important complementary information (Guralnik et al., 1994).
Monitoring these changes allows adjustments to your diet and exercise regimen to prioritize muscle preservation. Research emphasizes the need for accurate muscle mass assessments to understand how GLP-1 medications affect body composition.
Tracking your body composition provides valuable insights into your program's effectiveness and allows for data-driven adjustments. ShapeScale's 3D body scanning technology offers precise body composition analysis, providing the data needed for informed decisions. Find a ShapeScale location near you to experience the benefits firsthand.
Your journey with GLP-1 medication is unique, and your treatment plan should be too. Regular evaluations with your healthcare provider are essential to assess the medication's effectiveness and make necessary adjustments.
Adapting your treatment plan based on your progress and response to the medication is key for optimal results. Open communication with your healthcare provider ensures your treatment strategy remains aligned with your evolving needs and goals. This collaborative approach allows for personalized care and maximizes the chances of achieving long-term success.
For professionals like personal trainers and weight management centers, integrating ShapeScale's technology can provide clients with visual progress updates, enhancing motivation and adherence to their plans. Explore ShapeScale's pricing plans to see how it can fit your business model.
GLP-1 medications can be powerful tools for weight loss, but they also present unique challenges. Understanding these hurdles and developing strategies to overcome them is key for long-term success and muscle maintenance. Let's explore some common obstacles and how to address them.
One common side effect of GLP-1 medications is appetite suppression. While helpful for weight loss, it can also make it challenging to consume enough nutrients and maintain energy for exercise. It's important to listen to your body, but don't skip meals.
Prioritize nutrient-dense foods and eat smaller, more frequent meals throughout the day to ensure adequate calorie and protein intake. This approach can help stabilize blood sugar and provide sustained energy for workouts.
Strategic meal planning is crucial to achieve adequate protein intake despite reduced appetite, potentially including protein supplements or leucine-enriched products (Churchward-Venne et al., 2013). Vitamin D status should be assessed and supplementation considered if deficient, particularly in elderly patients (Verreijen et al., 2015).
If you're struggling with a reduced appetite, talk to a registered dietitian. They can help create a meal plan that meets your nutritional needs while supporting your weight loss goals.
Another challenge some individuals face is a decrease in exercise motivation. Weight loss itself can sometimes lead to lower energy levels, and the appetite suppression from GLP-1 medications can exacerbate this. To combat this, start with light to moderate exercise and gradually increase the intensity and duration as your energy levels improve. Find activities you enjoy and schedule them into your day, treating them as important appointments. Working with a personal trainer can provide additional support and accountability.
GLP-1 medications can sometimes interfere with nutrient absorption, increasing the risk of deficiencies. Pay close attention to your protein intake, as it's essential for preserving muscle mass during weight loss. Aim for a minimum of 0.8 grams of protein per kilogram of body weight daily, or even higher as advised by your doctor or dietitian. Consider incorporating protein shakes or supplements if you're struggling to meet your protein needs through food alone.
It's also important to ensure you're getting enough essential vitamins and minerals. A balanced diet rich in fruits, vegetables, and whole grains can help, but a multivitamin might be beneficial. Regular blood work can help monitor nutrient levels and identify any deficiencies early on. Talk to your doctor about specific nutrient needs and whether supplementation is right for you.
Regular exercise, especially resistance training, is crucial for maintaining muscle mass while using GLP-1 medications. Strength training helps counteract potential muscle loss associated with rapid weight loss and boosts metabolism. Aim for at least two strength training sessions per week, targeting all major muscle groups. Incorporate exercises like squats, lunges, push-ups, and rows. If you're new to strength training, start with lighter weights and gradually increase the load as you get stronger.
Cardiovascular exercise is also important for overall health and can help support weight loss. Aim for at least 150 minutes of moderate-intensity cardio per week, such as brisk walking, jogging, or cycling. Listen to your body and adjust your exercise routine as needed. If you experience any unusual fatigue or discomfort, consult your doctor.
Remember, consistency is key. Making exercise a regular part of your routine will help you maintain muscle mass, improve your overall health, and maximize the benefits of GLP-1 medications.
Keeping track of your progress is key for successful weight management. Luckily, we have access to some pretty cool tech and tools that can make this process easier and more insightful, especially when using GLP-1 medications. These tools can help you stay motivated and informed about your body's changes, allowing you to adjust your strategy as needed.
While the number on the scale can be a helpful starting point, it doesn't tell the whole story. It's important to remember that you want to lose fat, not muscle. As mentioned earlier, some weight loss with GLP-1 medications can come from lean body mass, including muscle. 3D body scanning offers a precise way to measure your body composition, giving you a clear picture of changes in both fat mass and muscle mass.
This technology goes beyond simple weight measurements to provide detailed insights into your body's transformation. This is super helpful for understanding the true impact of your weight loss journey and ensuring you're on the right path to a healthier you. ShapeScale provides this advanced technology, making it easier than ever to monitor these crucial changes.
Regular exercise is a crucial component of any weight loss journey, especially when using GLP-1 medications. Mobile apps and wearable devices can be valuable tools for tracking your activity levels, how many calories you're consuming, and other important health metrics. They can also help you stay accountable and maintain consistency with your fitness goals.
By providing real-time feedback and progress reports, these tools empower you to make informed decisions about your diet and exercise routine. For example, the ShapeScale app helps users visualize their body composition changes over time. They can also integrate with other health platforms, creating a comprehensive overview of your wellness journey.
The data you collect from tracking tools isn't just for you; it's valuable information for your healthcare providers and dietitians, too. Sharing this data allows them to personalize your treatment plan and offer tailored guidance based on your progress and any challenges you might be facing.
This collaborative approach can significantly improve the effectiveness of GLP-1 therapy by ensuring your plan is optimized for your individual needs. Open communication with your healthcare team is essential for maximizing the benefits of your weight loss program. This personalized approach, combined with data-driven insights, can lead to more effective and sustainable weight management outcomes.
GLP-1 medications are constantly evolving, with ongoing research exploring new ways to enhance their benefits and address potential side effects. This section explores emerging research and the importance of integrating these medications into comprehensive health plans.
Exciting developments are on the horizon for GLP-1 medications. Researchers are actively investigating ways to mitigate muscle loss, a common concern during rapid weight loss. Studies suggest that combining GLP-1 therapies with other medications could preserve or even improve muscle mass.
Some research suggests that liraglutide and semaglutide may protect skeletal muscle against obesity-induced muscle atrophy via the SIRT1 pathway. Furthermore, scientific investigations have found that "GLP-1 regulates skeletal muscle remodeling to enhance exercise endurance via GLP-1R/AMPK pathway" (Drucker, 2018).
This research aims to develop treatments that specifically target muscle health while maximizing fat loss, offering a more comprehensive approach to weight management. Scientists are also exploring new GLP-1 drug delivery methods and formulations to improve patient convenience and adherence.
While GLP-1 medications can be highly effective, they work best when integrated into a holistic health plan. This includes personalized guidance from healthcare providers and registered dietitians. Research emphasizes the importance of optimizing nutrition, diet, and lifestyle counseling alongside GLP-1 medication therapy.
Studies involving interviews with dietitians have identified key elements to improve both the efficacy of GLP-1 treatments and patient outcomes. These elements include personalized dietary plans, strategies for managing side effects, and ongoing support to help patients maintain long-term lifestyle changes.
By addressing individual needs and challenges, healthcare professionals can help patients achieve sustainable weight loss and overall health improvements. Tools like 3D body scanning can provide accurate body composition data, further enhancing personalized treatment plans and progress monitoring. You can find a ShapeScale location to learn more about how this technology can support your weight management program.
GLP-1 medications mimic natural hormones that control appetite and blood sugar. They increase insulin release, suppress glucagon (which raises blood sugar), slow digestion (making you feel fuller longer), and act on the brain to further reduce appetite. This combination helps manage hunger and improve metabolic function, leading to weight loss. The primary mechanism of action for weight loss with these drugs is described as appetite inhibition and reduced energy intake, which leads to caloric restriction (Blundell et al., 2017).
While rapid weight loss can sometimes lead to more muscle loss than gradual weight loss, the relationship between GLP-1 agonists and muscle is complex. Systematic reviews and meta-analyses indicate that lean mass loss accounts for approximately 40% of total weight loss with semaglutide and up to 60% with liraglutide (Neeland et al., 2024).
However, some research suggests that these medications may improve muscle quality by reducing muscle fat infiltration, even as muscle quantity decreases (Drucker, 2018). You can take steps to preserve and even build muscle while using these medications by incorporating resistance training and a balanced diet.
The strongest evidence supports a combination of resistance training and adequate protein intake for preserving muscle mass during weight loss, including with GLP-1 agonists. Neither intervention alone appears to be as effective as the combination, suggesting a synergistic effect (Cermak et al., 2012; Morton et al., 2018).
For resistance training, aim for moderate to high intensity resistance exercise performed 2-3 times per week for 30-60 minutes per session (Stastny et al., 2016). Regarding protein intake, higher than RDA (0.8g/kg/day) is recommended, with specific recommendations ranging from 1.0-1.6 g/kg/day (Deutz et al., 2014). Distribution of protein intake across meals is important, with a target of 25-30g of high-quality protein per meal to maximally stimulate muscle protein synthesis (Paddon-Jones & Rasmussen, 2009).
While the scale is a useful tool, it doesn't show changes in body composition. 3D body scanning provides a more comprehensive picture, measuring changes in both fat and muscle mass. Initial body composition assessment is important before starting GLP-1 agonists, ideally using DEXA or bioelectrical impedance analysis (Lee & Gallagher, 2008).
Regular monitoring of body composition during treatment helps track changes in muscle mass. Functional assessments (strength testing, physical performance measures) provide important complementary information (Guralnik et al., 1994). Mobile apps and wearables can also help track activity levels, calorie intake, and other health metrics. Share this data with your healthcare provider for personalized guidance.
Research is ongoing to improve GLP-1 therapies. Scientists are exploring ways to minimize muscle loss, improve drug delivery methods, and create more targeted treatments. Researchers are actively investigating ways to mitigate muscle loss during rapid weight loss, with studies suggesting that combining GLP-1 therapies with other medications could preserve or even improve muscle mass (Matthews et al., 2019).
The focus is on developing a more holistic approach to weight management that combines medication with personalized lifestyle changes, including diet, exercise, and ongoing support from healthcare professionals. Some research suggests that GLP-1 agonists may have direct effects on muscle metabolism beyond just caloric restriction, as studies have found that "GLP-1 regulates skeletal muscle remodeling to enhance exercise endurance via GLP-1R/AMPK pathway" (Drucker, 2018).
Areta, J. L., Burke, L. M., Ross, M. L., Camera, D. M., West, D. W. D., Broad, E. M., Jeacocke, N. A., Moore, D. R., Stellingwerff, T., Phillips, S. M., Hawley, J. A., & Coffey, V. G. (2013). Timing and distribution of protein ingestion during prolonged recovery from resistance exercise alters myofibrillar protein synthesis. The Journal of Physiology, 591(9), 2319-2331.
Blundell, J., Finlayson, G., Axelsen, M., Flint, A., Gibbons, C., Kvist, T., & Hjerpsted, J. B. (2017). Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes, Obesity and Metabolism, 19(9), 1242-1251.
Breen, L., Stokes, K. A., Churchward-Venne, T. A., Moore, D. R., Baker, S. K., Smith, K., Atherton, P. J., & Phillips, S. M. (2013). Two weeks of reduced activity decreases leg lean mass and induces "anabolic resistance" of myofibrillar protein synthesis in healthy elderly. The Journal of Clinical Endocrinology & Metabolism, 98(6), 2604-2612.
Cermak, N. M., Res, P. T., de Groot, L. C., Saris, W. H., & van Loon, L. J. (2012). Protein supplementation augments the adaptive response of skeletal muscle to resistance-type exercise training: A meta-analysis. The American Journal of Clinical Nutrition, 96(6), 1454-1464.
Churchward-Venne, T. A., Murphy, C. H., Longland, T. M., & Phillips, S. M. (2013). Role of protein and amino acids in promoting lean mass accretion with resistance exercise and attenuating lean mass loss during energy deficit in humans. Amino Acids, 45(2), 231-240.
Deutz, N. E., Bauer, J. M., Barazzoni, R., Biolo, G., Boirie, Y., Bosy-Westphal, A., Cederholm, T., Cruz-Jentoft, A., Krznariç, Z., Nair, K. S., Singer, P., Teta, D., Tipton, K., & Calder, P. C. (2014). Protein intake and exercise for optimal muscle function with aging: Recommendations from the ESPEN Expert Group. Clinical Nutrition, 33(6), 929-936.
Drucker, D. J. (2018). Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metabolism, 27(4), 740-756.
Grumati, P., & Bonaldo, P. (2012). Autophagy in skeletal muscle homeostasis and in muscular dystrophies. Cells, 1(3), 325-345.
Guralnik, J. M., Simonsick, E. M., Ferrucci, L., Glynn, R. J., Berkman, L. F., Blazer, D. G., Scherr, P. A., & Wallace, R. B. (1994). A short physical performance battery assessing lower extremity function: Association with self-reported disability and prediction of mortality and nursing home admission. Journal of Gerontology, 49(2), M85-M94.
Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., & Stefanski, A. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216.
Kahan, S., Fujioka, K., & Kajiwara, N. M. (2023). Practical approaches to weight regain after bariatric surgery. Obesity, 31(1), 25-36.
Lecker, S. H., Goldberg, A. L., & Mitch, W. E. (2006). Protein degradation by the ubiquitin--proteasome pathway in normal and disease states. Journal of the American Society of Nephrology, 17(7), 1807-1819.
Lee, S. Y., & Gallagher, D. (2008). Assessment methods in human body composition. Current Opinion in Clinical Nutrition and Metabolic Care, 11(5), 566-572.
Matthews, G. D. K., Huang, C. L. H., Sun, L., & Zaidi, M. (2019). Translational musculoskeletal science: Is sarcopenia the next clinical target after osteoporosis? Annals of the New York Academy of Sciences, 1442(1), 140-157.
Morton, R. W., Murphy, K. T., McKellar, S. R., Schoenfeld, B. J., Henselmans, M., Helms, E., Aragon, A. A., Devries, M. C., Banfield, L., Krieger, J. W., & Phillips, S. M. (2018). A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. British Journal of Sports Medicine, 52(6), 376-384.
Neeland, I. J., Marso, S. P., Ayers, C. R., Lewis, B., McCoy, R., Bauer, D. C., Lash, D. S., & Lingvay, I. (2024). Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies. Diabetes, Obesity and Metabolism, 26(3), 753-766.
O'Neil, P. M., Birkenfeld, A. L., McGowan, B., Mosenzon, O., Pedersen, S. D., Wharton, S., Carson, C. G., Jepsen, C. H., Kabisch, M., & Wilding, J. P. H. (2018). Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: A randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. The Lancet, 392(10148), 637-649.
Paddon-Jones, D., & Rasmussen, B. B. (2009). Dietary protein recommendations and the prevention of sarcopenia. Current Opinion in Clinical Nutrition and Metabolic Care, 12(1), 86-90.
Stastny, P., Tufano, J. J., Golas, A., & Petr, M. (2016). Strengthening the gluteus medius using various bodyweight and resistance exercises. Strength & Conditioning Journal, 38(3), 91-101.
Verreijen, A. M., Verlaan, S., Engberink, M. F., Swinkels, S., de Vogel-van den Bosch, J., & Weijs, P. J. (2015). A high whey protein-, leucine-, and vitamin D-enriched supplement preserves muscle mass during intentional weight loss in obese older adults: A double-blind randomized controlled trial. The American Journal of Clinical Nutrition, 101(2), 279-286.
Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002.